Nasdaq Issues Compliance Notice to EUDA Health Over Market Value Shortfall

Event summary

  • Nasdaq notified EUDA Health on April 23, 2026, that it failed to maintain a minimum market value of $35M for 32 consecutive business days.
  • The company has until October 20, 2026, to regain compliance or face potential delisting.
  • EUDA must achieve a market value of at least $35M for 10 consecutive business days during the compliance period.
  • The company operates as a non-invasive healthcare provider in Asia, with a focus on Singapore, Malaysia, and China.

The big picture

EUDA Health’s compliance notice highlights the challenges faced by smaller-cap healthcare providers in maintaining market stability. The company’s focus on non-invasive and preventive healthcare in rapidly aging Asian markets positions it within a growing sector, but its ability to navigate regulatory and market pressures will be critical. The outcome of this compliance period could influence investor confidence and strategic decisions in the broader healthcare sector.

What we're watching

Market Recovery
Whether EUDA can stabilize its market value above $35M within the 180-day compliance window.
Strategic Adjustments
How EUDA plans to address the underlying factors contributing to its market value decline.
Regulatory Dynamics
The potential impact of Nasdaq’s compliance requirements on EUDA’s operational and financial strategies.